Additionally, one study noted that COVID-19-affected patients with DM as a sole comorbidity had a 16.5% mortality rate compared to 0% in comorbidity free COVID-19 patients, whereas another reported poor outcomes in COVID-19 inpatients with uncontrolled hyperglycemia compared to their euglycemic counterparts.